Product Information
ZIPRASIDONE HCL 40 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2671 per EA under NDC 33342014509. Its NADAC has been published 471 times since Aug 16, 2017.
FDA first approved this application on Feb 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342014509
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ZIPRASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204375FDA Approved
2/17/2017
TE Code
AB
On Market Since
2/18/2017
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has been published 471 times since Aug 16, 2017, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2671 per EA |
|---|---|
| All-time high | $0.5657 (Sep 13, 2017) |
| All-time low | $0.1879 (Nov 20, 2024) |
| 52-week high | $0.2786 |
| 52-week low | $0.2548 |
| Median price | $0.2979 |
| Average price | $0.3179 |
| Largest weekly change | +41.5% (Sep 23, 2020) |
| Weeks tracked | 471 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIPRASIDONE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 40 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.2671 per EA (NDC 33342014509), effective Aug 19, 2026.
How has the price of ZIPRASIDONE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has declined 51.2%. It has been tracked across 471 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 40 MG CAPSULE?
Since Aug 16, 2017, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has ranged from a low of $0.1879 (Nov 20, 2024) to a high of $0.5657 (Sep 13, 2017), with a median of $0.2979 per EA.
Are there cheaper alternatives to ZIPRASIDONE HCL 40 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZIPRASIDONE HCL 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ZIPRASIDONE HCL 40 MG CAPSULE?
ZIPRASIDONE HCL 40 MG CAPSULE (NDC 33342014509) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.